HLB Pep Co., Ltd. Logo

HLB Pep Co., Ltd.

Develops and produces GMP peptides, APIs, and custom synthesis for the biopharma industry.

196300 | KO

Overview

Corporate Details

ISIN(s):
N/A
LEI:
Country:
South Korea
Address:
광주광역시 북구 첨단과기로 333 광주테크노파크 시험생산동 206호 , 광주광역시
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

HLB Pep Co., Ltd. is a biotechnology company that develops and produces therapeutic peptides and peptide-based biomaterials. The company's core activities include the manufacture and sale of Active Pharmaceutical Ingredients (APIs) from its GMP-certified facility, which was the first of its kind in Korea dedicated to peptide production. Its product and service portfolio consists of GMP and generic peptides, custom peptide synthesis for specific client requirements, and an extensive catalog of approximately 1,000 research peptides, including hormones, neuropeptides, and neurotoxins. HLB Pep focuses on research and development to discover new drug candidates, aiming to commercialize its innovations and expand its presence as a global biopharmaceutical firm.

This is a Fraction of the Available Data.

You're viewing a limited, static snapshot. Professionals use our API to get real-time, AI-ready data for HLB Pep Co., Ltd. and 9,000+ other companies.

Stop analyzing yesterday's news. Start building a real-time advantage.

Request Enterprise API Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all HLB Pep Co., Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for HLB Pep Co., Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Hana Pharm. Co., Ltd. Logo
Pharmaceutical firm specializing in anesthetics and narcotic analgesics for global markets.
South Korea 293480
Hanmi Pharm. Co., Ltd. Logo
Biopharma firm developing innovative diabetes and cancer drugs for patients and professionals.
South Korea 128940
Hansa Biopharma Logo
Develops antibody-cleaving enzymes to treat rare diseases and enable organ transplants.
Sweden HNSA
HEALIOS K.K. Logo
Develops iPS and somatic stem cell therapies for diseases like ARDS and cancer.
Japan 4593
Heartseed株式会社 Logo
Develops iPSC-derived cell therapies to regenerate heart tissue for heart failure.
Japan 219A
HELLENIC DYNAMICS PLC Logo
Cultivates and supplies THC-dominant medical cannabis for the European pharmaceutical market.
United Kingdom HELD
HEMOGENYX PHARMACEUTICALS PLC Logo
Develops CAR-T therapies for blood cancers, autoimmune disorders, and viral infections.
United Kingdom HEMO
HEM Pharma Inc. Logo
Microbiome biotech using analysis for personalized probiotics, LBPs, and full CDMO services.
South Korea 376270
Hemp Health Spolka Akcyjna Logo
A vertically integrated supplier of medical cannabis raw material for the Polish market.
Poland HMP
Herantis Pharma Oyj Logo
Developing disease-modifying therapies for neurodegenerative conditions like Parkinson's disease.
Finland HRTIS

Talk to a Data Expert

Have a question? We'll get back to you promptly.